Zydus gets EIR for SEZ II manufacturing facility in Ahmedabad
Written By : Ruchika Sharma
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2025-11-05 07:15 GMT | Update On 2025-11-05 07:15 GMT
Advertisement
Ahmedabad: Zydus has announced that the company has received an Establishment Inspection Report (EIR) from the United States Food and Drugs Administration (USFDA) for the group’s manufacturing plant located at SEZ – II, Ahmedabad.
The Pre-Approval Inspection (PAI) was held from 11th to 14th August 2025. The USFDA has concluded this inspection as closed.
The inspection concluded with NIL observations. The EIR has classified the facility as No Action Indicated (NAI).
Zydus Lifesciences Ltd. is an innovative, global lifesciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group has a significant presence in cancer related therapies and offers a wide range of solutions with cytotoxic, supportive & targeted drugs.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.